SEC Filing | Company/Stock | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Gain/Loss |
---|---|---|---|---|---|---|---|---|
06-Mar-23 8:43 PM View: | Carisma Therapeutics Inc. (CARM) | 02-Mar-23 | Option Exercise | 606,800 | $0.59 | $356,192.00 | 110% 553.07K to 1.16M | |
06-Mar-23 8:43 PM View: | Carisma Therapeutics Inc. (CARM) | 02-Mar-23 | Option Sale | 487,487 | $0.59 | $286,155.00 | (42%) 1.16M to 672.39K | |
23-Feb-23 7:35 PM View: | Carisma Therapeutics Inc. (CARM) | 21-Feb-23 | Sale | 53,727 | $0.59 | $31,553.90 | (9%) 606.8K to 553.07K | |
23-Feb-22 8:36 PM View: | Carisma Therapeutics Inc. (CARM) | 18-Feb-22 | Grant | 606,800 | -- | -- | 100% 0 to 606.8K | |
02-Jun-17 4:33 PM View: | Orexigen Therapeutics, Inc. (OREXQ) | 31-May-17 | Grant | 2,119 | $1.55 | $3,284.45 | 120% 1.76K to 3.88K | |
02-Dec-16 5:09 PM View: | Orexigen Therapeutics, Inc. (OREXQ) | 30-Nov-16 | Grant | 291 | $1.67 | $485.97 | 20% 1.47K to 1.76K | |
02-Jun-16 11:22 AM View: | Orexigen Therapeutics, Inc. (OREXQ) | 31-May-16 | Grant | 9,632 | $0.34 | $3,274.88 | 189% 5.09K to 14.72K | |
04-Feb-16 12:06 PM View: | Orexigen Therapeutics, Inc. (OREXQ) | 30-Nov-15 | Grant | 5,091 | $2.03 | $10,334.70 | 100% 0 to 5.09K |